Stephanie L. Lee MD, PhD

Professor, Endocrinology, Diabetes, Nutrition & Weight Management

720 Harrison Ave | (617) 638-8530
sltal@bu.edu
stephanie.lee@bmc.org

Sections

Endocrinology, Diabetes, Nutrition & Weight Management

Centers

BU-BMC Cancer Center

Evans Center for Interdisciplinary Biomedical Research

Biography

Stephanie L. Lee, Ph.D., M.D., F.A.C.E., E.C.N.U graduated from UC San Diego with a MD and PhD in Physiology and Pharmacology and completed a molecular and clinical fellowship in Endocrinology. Her research interests are to improve the methods to diagnosis and manage thyroid cancer.

Websites

BU Profile

Boston Medical Center Provider Profile

BU Nanotechnology Innovation Center (BUnano)

World Congress on Thyroid Cancer Profile

ResearchGate

Education

MD, University of California, San Diego, 1982

PhD, University of California, San Diego, 1980

BA, University of California, Santa Barbara, 1975

Publications

Published on 10/31/2022

Sarkar R, Lee SL, Kumar V, Thakur S. Editorial: Thyroid cancer: New perspectives in diagnosis and therapy. Front Pharmacol. 2022; 13:1057731. PMID: 36386151.

PubMed

Published on 2/14/2022

Pence A, McGrath M, Lee SL, Raines DE. Pharmacological management of severe Cushing's syndrome: the role of etomidate. Ther Adv Endocrinol Metab. 2022; 13:20420188211058583. PMID: 35186251.

PubMed

Published on 5/19/2021

Goundan PN, Mamou J, Rohrbach D, Smith J, Patel H, Wallace KD, Feleppa EJ, Lee SL. A Preliminary Study of Quantitative Ultrasound for Cancer-Risk Assessment of Thyroid Nodules. Front Endocrinol (Lausanne). 2021; 12:627698. PMID: 34093429.

PubMed

Published on 12/15/2020

Haddady S, Pinjic E, Lee SL. Prognostic Value of Serum Thyroglobulin Measured at 48 Hours Versus 72 Hours after Second Dose of Recombinant Human Thyrotropin in Surveillance of Well-Differentiated Thyroid Cancer. Endocr Pract. 2021 Mar; 27(3):216-222. PMID: 33779554.

PubMed

Published on 12/3/2020

Vodopivec DM, Thomas DD, Palermo NE, Steenkamp DW, Lee SL. Looking for the Outsider. N Engl J Med. 2020 12 03; 383(23):2275-2281. PMID: 33264549.

PubMed

Published on 11/1/2020

Guan H, Toraldo G, Godley FA, Rao SR, Cerda S, McAneny D, Doherty G, Lee SL. The real-world performance of ThyroSeqV.2 to diagnose thyroid "neoplasm requiring surgery". Am J Cancer Res. 2020; 10(11):3838-3851. PMID: 33294271.

PubMed

Published on 10/1/2020

Goundan PN, Lee SL. Thyroid effects of amiodarone: clinical update. Curr Opin Endocrinol Diabetes Obes. 2020 10; 27(5):329-334. PMID: 32773570.

PubMed

Published on 7/23/2020

Chung R, Guan H, Ponchiardi C, Cerda S, Marwaha N, Yilmaz OH, Pinjic E, McAneny D, Lee SL, Drake FT. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort. Thyroid. 2021 01; 31(1):68-75. PMID: 32539676.

PubMed

Published on 6/19/2020

Fazeli SR, Zehr B, Amraei R, Toraldo G, Guan H, Kindelberger D, Lee S, Cerda S. ThyroSeq v2 Testing: Impact on Cytologic Diagnosis, Management, and Cost of Care in Patients with Thyroid Nodule. Thyroid. 2020 10; 30(10):1528-1534. PMID: 32349630.

PubMed

Published on 2/20/2020

Guan H, Toraldo G, Cerda S, Godley FA, Rao SR, McAneny D, Doherty G, Braverman L, Lee SL. Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort. Thyroid. 2020 04; 30(4):536-547. PMID: 31996097.

PubMed

View full list of 72 publications.